08 Mar '22
REDWOOD CITY, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the fourth quarter and full year ended...
14 Feb '22
– Symptom reduction and uroflow improvement proved durable and consistent compared to TURP – Larger prostates (≥50 ml) demonstrated a larger safety and efficacy benefit for Aquablation over TURP – 5-year Aquablation retreatment rate was 51% less compared to TURP REDWOOD CITY, Calif., Feb....
Displaying 1 - 10 of 14